Arovella Therapeutics Ltd: Appendix 4E and Annual Report

Aug 21 19:43 ET · Announcements

Arovella Therapeutics Receives Positive Feedback From US FDA for Blood Cancer Treatment; Shares Jump 7%

MT NewswiresAug 6 21:32 ET

Arovella's ALA-101 Gains FDA Nod Towards Trials

TipRanksAug 6 20:09 ET

Arovella Therapeutics, Teva Pharmaceuticals End ZolpiMist License Agreement

MT NewswiresJun 12 23:22 ET

Arovella Therapeutics Completes Process Development for ALA-101 Manufacturing; Shares Jump 9%

MT NewswiresJun 4 23:10 ET

Arovella Therapeutics Receives Firm Commitments for About AU$12.5 Million Raise

MT NewswiresMar 25 21:50 ET